SCI Pharmtech, Inc. (TPE:4119)
Taiwan · Delayed Price · Currency is TWD 57.70
+0.10 (0.17%)
Sep 19, 2025, 11:38 AM CST
SCI Pharmtech Market Cap
SCI Pharmtech has a market cap or net worth of 6.90 billion as of September 18, 2025. Its market cap has decreased by -35.24% in one year.
Market Cap
6.90B
Enterprise Value
7.44B
Revenue
1.55B
Ranking
n/a
PE Ratio
14.25
Stock Price
57.70
Market Cap Chart
Since January 5, 2004, SCI Pharmtech's market cap has increased from 1.06B to 6.90B, an increase of 547.62%. That is a compound annual growth rate of 8.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 6.90B | -36.31% |
| Dec 31, 2024 | 10.83B | -6.40% |
| Dec 29, 2023 | 11.57B | 24.39% |
| Dec 30, 2022 | 9.30B | 16.07% |
| Dec 30, 2021 | 8.01B | 20.00% |
| Dec 31, 2020 | 6.68B | -21.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 307.10B |
| PharmaEssentia | 178.82B |
| Bora Pharmaceuticals Co., LTD. | 86.38B |
| Lumosa Therapeutics | 53.57B |
| Lotus Pharmaceutical | 49.05B |
| Oneness Biotech | 32.86B |
| Polaris Group | 29.01B |
| Center Laboratories | 27.60B |